18.757 articles found

Effects of early and delayed treatment with an mGluR5 antagonist on motor impairment, nigrostriatal damage and neuroinflammation in a rodent model of Parkinson's disease.

Ambrosi G, Armentero MT, Levandis G, Bramanti P, Nappi G, Blandini F.

Brain Res Bull · 2010-01-25

DOI: 10.1016/j.brainresbull.2010.01.011PMID: 20100549

The causal relationship between subcortical local field potential oscillations and Parkinsonian resting tremor.

Tass P, Smirnov D, Karavaev A, Barnikol U, Barnikol T, Adamchic I, Hauptmann C, Pawelcyzk N, Maarouf M, Sturm V, Freund HJ, Bezruchko B.

J Neural Eng · 2010-01-19

DOI: 10.1088/1741-2560/7/1/016009PMID: 20083863

Movement correction method for human brain PET images: application to quantitative analysis of dynamic 18F-FDDNP scans.

Wardak M, Wong KP, Shao W, Dahlbom M, Kepe V, Satyamurthy N, Small GW, Barrio JR, Huang SC.

J Nucl Med · 2010-01-15

DOI: 10.2967/jnumed.109.063701PMID: 20080894

Digitized spiral analysis is a promising early motor marker for Parkinson Disease.

Stanley K, Hagenah J, Brüggemann N, Reetz K, Severt L, Klein C, Yu Q, Derby C, Pullman S, Saunders-Pullman R.

Parkinsonism Relat Disord · 2010-01-15

DOI: 10.1016/j.parkreldis.2009.12.007PMID: 20079674

L-DOPA treatment reverses the motor alterations induced by manganese exposure as a Parkinson disease experimental model.

Ordoñez-Librado JL, Anaya-Martinez V, Gutierrez-Valdez AL, Montiel-Flores E, Corona DR, Martinez-Fong D, Avila-Costa MR.

Neurosci Lett · 2010-01-15

DOI: 10.1016/j.neulet.2010.01.015PMID: 20079802

MK-801 inhibits L-DOPA-induced abnormal involuntary movements only at doses that worsen parkinsonism.

Paquette MA, Anderson AM, Lewis JR, Meshul CK, Johnson SW, Paul Berger S.

Neuropharmacology · 2010-01-14

DOI: 10.1016/j.neuropharm.2010.01.003PMID: 20079362

Evidence for motor learning in Parkinson's disease: acquisition, automaticity and retention of cued gait performance after training with external rhythmical cues.

Rochester L, Baker K, Hetherington V, Jones D, Willems AM, Kwakkel G, Van Wegen E, Lim I, Nieuwboer A.

Brain Res · 2010-01-11

DOI: 10.1016/j.brainres.2010.01.001PMID: 20064492

Reversing cognitive-motor impairments in Parkinson's disease patients using a computational modelling approach to deep brain stimulation programming.

Frankemolle AM, Wu J, Noecker AM, Voelcker-Rehage C, Ho JC, Vitek JL, McIntyre CC, Alberts JL.

Brain · 2010-01-07

DOI: 10.1093/brain/awp315PMID: 20061324

Hiccups in Parkinson's disease: an overlooked non-motor symptom?

Miwa H, Kondo T.

Parkinsonism Relat Disord · 2010-01-06

DOI: 10.1016/j.parkreldis.2009.12.004PMID: 20056471

Dopamine influences primary motor cortex plasticity and dorsal premotor-to-motor connectivity in Parkinson's disease.

Suppa A, Iezzi E, Conte A, Belvisi D, Marsili L, Modugno N, Fabbrini G, Berardelli A.

Cereb Cortex · 2010-01-05

DOI: 10.1093/cercor/bhp288PMID: 20051362

Clinical and PET imaging studies in Parkinson's disease motor and non-motor complications : serotonergic and dopamimergic mechanisms and applications in treatment

Politis M.

· 2010-01-01

Non-motor symptons in Parkinson's disease including the dopamine dysregulation syndrome and impulse control

O'Sullivan SS.

· 2010-01-01